The German life-science and chemicals company attributed earnings growth to a recovery of its life-science segment, cost discipline and lower spending on research and development following the ...

FRANKFURT, Nov 14 (Reuters) - Merck KGaA (MRCG.DE), opens ... which makes gear and supplies for biotech labs, continues to ...

Modifi Bio’s innovative approach has the potential for treating some of the cancer types that are often most unresponsive to ...

The market for multiplex biomarker imaging is anticipated to reach a valuation of USD 1,631.4 million by 2034, up from USD ...

At a research lab in the city of Hefei ... The experiment in August could offer a new approach to eco-friendly chemical production, according to the researchers. The research also indicated ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced a $76 million expansion of its ADC manufacturing ...

VANCOUVER, Wash. and SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI) a data-first generative AI ...

Merck & Co. has bought a Yale University spinout called Modifi Biosciences for $30 million up front and the potential for more than $1.3 billion in milestone payments. Modifi is developing small ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...